New tuberculosis drugs on the horizon
- PMID: 21821466
- DOI: 10.1016/j.mib.2011.07.022
New tuberculosis drugs on the horizon
Abstract
Tuberculosis (TB) remains a major global health concern whose control has been exacerbated by HIV and the emergence of multidrug-resistant (MDR-TB) and extensively drug-resistant (XDR-TB) strains of Mycobacterium tuberculosis. The demand for new and faster acting TB drugs is thus greater than ever. In the past decade intensive efforts have been made to discover new leads for TB drug development using both target-based and cell-based approaches. Here, we describe the most promising anti-tubercular drug candidates that are in clinical development and introduce some nitro-aromatic compounds that inhibit a new target, DprE1, an essential enzyme involved in a crucial step in mycobacterial cell wall biosynthesis.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Worldwide emergence of extensively drug-resistant tuberculosis.Emerg Infect Dis. 2007 Mar;13(3):380-7. doi: 10.3201/eid1303.061400. Emerg Infect Dis. 2007. PMID: 17552090 Free PMC article.
-
Recent advances in the research of heterocyclic compounds as antitubercular agents.ChemMedChem. 2012 Dec;7(12):2063-75. doi: 10.1002/cmdc.201200339. Epub 2012 Oct 5. ChemMedChem. 2012. PMID: 23042656 Review.
-
Challenges and opportunities in developing novel drugs for TB.Future Med Chem. 2011 Sep;3(11):1373-400. doi: 10.4155/fmc.11.115. Future Med Chem. 2011. PMID: 21879843 Review.
-
Extensively drug-resistant tuberculosis: current challenges and threats.FEMS Immunol Med Microbiol. 2008 Jul;53(2):145-50. doi: 10.1111/j.1574-695X.2008.00400.x. Epub 2008 May 8. FEMS Immunol Med Microbiol. 2008. PMID: 18479439 Review.
Cited by
-
Experimental Design-Based Response Surface Methodology Optimization for Synthesis of β-Mercapto Carbonyl Derivatives as Antimycobacterial Drugs Catalyzed by Calcium Pyrophosphate.Int J Med Chem. 2014;2014:586437. doi: 10.1155/2014/586437. Epub 2014 Mar 6. Int J Med Chem. 2014. PMID: 25383218 Free PMC article.
-
Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis.Sci Transl Med. 2012 Sep 5;4(150):150ra121. doi: 10.1126/scitranslmed.3004395. Sci Transl Med. 2012. PMID: 22956199 Free PMC article.
-
Decaprenylphosphoryl-β-d-ribose 2'-Epimerase 1 (DprE1): A Novel Therapeutic Target for the Treatment of Tuberculosis.ACS Med Chem Lett. 2015 Feb 26;6(4):373-4. doi: 10.1021/acsmedchemlett.5b00080. eCollection 2015 Apr 9. ACS Med Chem Lett. 2015. PMID: 25941552 Free PMC article. No abstract available.
-
In vitro combination studies of benzothiazinone lead compound BTZ043 against Mycobacterium tuberculosis.Antimicrob Agents Chemother. 2012 Nov;56(11):5790-3. doi: 10.1128/AAC.01476-12. Epub 2012 Aug 27. Antimicrob Agents Chemother. 2012. PMID: 22926573 Free PMC article.
-
DnaG Primase-A Target for the Development of Novel Antibacterial Agents.Antibiotics (Basel). 2018 Aug 13;7(3):72. doi: 10.3390/antibiotics7030072. Antibiotics (Basel). 2018. PMID: 30104489 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
